About Hyaluronic Acid
Hyaluronic acid (HA) or glass acid is a naturally occurring non-sulfated glycosaminoglycan. It is present in the human body in the joints, eye cavity, and internal defense systems. It functions as a nutrient carrier, along with helping the tissues in retaining water. It is an integral part of the extracellular matrix and is found in the coverings around chondrocytes. HA is produced commercially by various processes, including extraction from animal tissues, bacterial production, and in-vitro production. Its major medical applications are viscosupplementation for osteoarthritis, ophthalmic, VUR, and dermal fillers. HA is commercially available in the form of single-injection cycle HA products, three-injection cycle HA products, and five-injection cycle HA products.
TechNavio's analysts forecast the Global HA Market will grow at a CAGR of 9.14 percent over the period 2013-2018.
Covered in this Report
The Global HA market can be divided on the basis of application into the following segments: Dermal Fillers, Osteoarthritis, Ophthalmic, and VUR.
TechNavio's report, the Global HA Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, the APAC region, and the ROW; it also covers the Global HA Market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• North America
• Europe
• APAC
• ROW
Key Vendors
• Allergan
• Ferring Pharmaceuticals
• Fidia Farmaceutici
• Sanofi
• Seikagaku
Other Prominent Vendors
• Abbott Medical Optics
• Abdi Ibrahim
• Alcon
• Alveda
• Angelini
• Anika Therapeutics
• AstraZeneca
• Bausch & Lomb
• Bayer
• Biomet
• Bioniche Teoranta
• Boustead Group of Companies
• Bruschettini
• Cadila Healthcare
• Choseido Pharmaceutical
• Contipro Biotech
• Daiichi-Sankyo
• Documedica
• Expanscience
• F. Hoffmann-La Roche
• Galderma
• Genzyme
• HTL Biotechnology
• Hyaltech
• Lifecore Biomedical
• Lipo Chemicals
• Meiji Seika Pharma
• Merz Aesthetics
• Nordic Drugs
• Novozymes
• Salix Pharmaceuticals
• Shandong Freda Biochem
• Shanghai Jingfeng Pharmaceutical
• Smith & Nephew
• Teijin Pharma
• TRB Chemedica International
• Zimmer Holdings
Key Market Driver
• Rise in Geriatric Population
• For a full, detailed list, view our report
Key Market Challenge
• Threat of Substitution for Osteoarthritis
• For a full, detailed list, view our report
Key Market Trend
• Shift in Consumer Preference for Single-Injection Cycle HA Products
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 HA Production Process
06.2 Market Overview
07. Global HA Market
07.1 Market Size and Forecast
07.2 Five Forces Analysis
08. Market Segmentation by Application
08.1 Global HA Market Segmentation by Application 2013-2018
08.2 Global HA Market in Dermal Fillers
08.2.1 Market Size and Forecast
08.3 Global HA Market for Osteoarthritis
08.3.1 Market Size and Forecast
08.4 Global HA Market for VUR
08.4.1 Market Size and Forecast
08.5 Global HA Market in Ophthalmic
08.5.1 Market Size and Forecast
09. Market Segmentation by Product
09.1 Global HA Market Segmentation by Product 2013-2018
09.2 Global Single-Injection Cycle HA Products Market
09.2.1 Market Size and Forecast
09.3 Global Three-Injection Cycle HA Products Market
09.3.1 Market Size and Forecast
09.4 Global Five-Injection Cycle HA Products Market
09.4.1 Market Size and Forecast
10. Geographical Segmentation
10.1 Global HA Market Segmentation by Geography 2013-2018
10.2 HA Market in North America
10.2.1 Market Size and Forecast
10.3 HA Market in Europe
10.3.1 Market Size and Forecast
10.4 HA Market in the APAC Region
10.4.1 Market Size and Forecast
10.5 HA Market in ROW
10.5.1 Market Size and Forecast
11. Key Leading Countries
11.1 US
11.2 France
11.3 Japan
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.2 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Allergan Inc.
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Revenue by Business Segmentation
20.1.5 Revenue Comparison 2011-2013
20.1.6 Revenue by Geographical Segmentation
20.1.7 Business Strategy
20.1.8 Key Developments
20.1.9 SWOT Analysis
20.2 Ferring Pharmaceuticals
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 SWOT Analysis
20.3 Fidia Farmaceutici
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Product Segmentation
20.3.4 Recent Developments
20.3.5 SWOT Analysis
20.4 Sanofi
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation by Revenue 2013
20.4.4 Business Segmentation by Revenue 2012 and 2013
20.4.5 Geographical Segmentation by Revenue 2013
20.4.6 Business Strategy
20.4.7 Key Developments
20.4.8 SWOT Analysis
20.5 Seikagaku
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Business Segmentation by Revenue 2013
20.5.4 Business Segmentation by Revenue 2012 and 2013
20.5.5 Business Strategy
20.5.6 SWOT Analysis
21. Other Reports in this Series
?
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: HA Production Process
Exhibit 3: Global HA Market Segmentation
Exhibit 4: Global HA Market Segmentation by Application
Exhibit 5: Global HA Market Segmentation by Product
Exhibit 6: Global HA Market Segmentation by Geography
Exhibit 7: Global HA Market 2013-2018 (US$ billion)
Exhibit 8: Global HA Market Segmentation by Application 2013-2018
Exhibit 9: Global HA Market Segmentation by Application 2013-2018 (Consolidated)
Exhibit 10: Global HA Market in Dermal Fillers 2013-2018 (US$ billion)
Exhibit 11: Global HA Market for Osteoarthritis 2013-2018 (US$ billion)
Exhibit 12: Global HA Market in VUR 2013-2018 (US$ billion)
Exhibit 13: Global HA Market in Ophthalmic 2013-2018 (US$ billion)
Exhibit 14: Global HA Market Segmentation by Product 2013-2018
Exhibit 15: Global HA Market Segmentation by Product 2013-2018 (Consolidated)
Exhibit 16: Global Single-Injection Cycle HA Products Market 2013-2018 (US$ billion)
Exhibit 17: Global Three-Injection Cycle HA Products Market 2013-2018 (US$ billion)
Exhibit 18: Global Five-Injection Cycle HA Products Market 2013-2018 (US$ billion)
Exhibit 19: Global HA Market Segmentation by Geography 2013-2018
Exhibit 20: Global HA Market Segmentation by Geography 2013-2018 (Consolidated)
Exhibit 21: HA Market in North America 2013-2018 (US$ billion)
Exhibit 22: HA Market in Europe 2013-2018 (US$ billion)
Exhibit 23: HA Market in the APAC Region 2013-2018 (US$ billion)
Exhibit 24: HA Market in ROW 2013-2018 (US$ billion)
Exhibit 25: Aging Population Above 60 and its Growth Rate 1995-2050 (in millions)
Exhibit 26: Allergan Inc.: Business Segmentation
Exhibit 27: Allergan Inc.: Revenue by Business Segmentation 2013
Exhibit 28: Allergan Inc.: Revenue Comparison by Business Segmentation 2011-2013 (US$ billion)
Exhibit 29: Allergan Inc.: Revenue by Geographical Segmentation 2013
Exhibit 30: Fidia Farmaceutici : Product Segmentation 2013
Exhibit 31: Sanofi: Business Segmentation by Revenue 2013
Exhibit 32: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 33: Sanofi: Geographical Segmentation by Revenue 2013
Exhibit 34: Seikagaku: Business Segmentation by Revenue 2013
Exhibit 35: Seikagaku: Business Segmentation by Revenue 2012 and 2013 (US$ million)
